2021
ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance)
Weiss A, Campbell J, Ballman K, Sikov W, Carey L, Hwang E, Poppe M, Partridge A, Ollila D, Golshan M. ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Annals Of Surgical Oncology 2021, 28: 436-437. DOI: 10.1245/s10434-021-10005-1.Peer-Reviewed Original ResearchSurvival Benefits Associated with Surgery in Patients with Metastatic Breast Cancer by Breast Cancer Subtype
Han H, . T, Yu J, Golshan M, Hsu H, Chu C, Hong Z, Fu C, Chou Y, Dai M, Liao G. Survival Benefits Associated with Surgery in Patients with Metastatic Breast Cancer by Breast Cancer Subtype. Journal Of Cancer Science And Clinical Therapeutics 2021, 05 DOI: 10.26502/jcsct.5079127.Peer-Reviewed Original Research
2018
25 Examination Techniques Roles of the Physician and Patient in Evaluating Breast Disease
Mallory M, Golshan M. 25 Examination Techniques Roles of the Physician and Patient in Evaluating Breast Disease. 2018, 331-336.e2. DOI: 10.1016/b978-0-323-35955-9.00025-8.Peer-Reviewed Original Research
2017
170P Impact of neoadjuvant therapy (NT) and pathological complete response (pCR) on breast-conserving surgery (BCS) in patients (pts) with breast cancer (BC): A meta-analysis
Criscitiello C, Golshan M, Barry W, Viale G, Wong S, Santangelo M, Curigliano G. 170P Impact of neoadjuvant therapy (NT) and pathological complete response (pCR) on breast-conserving surgery (BCS) in patients (pts) with breast cancer (BC): A meta-analysis. Annals Of Oncology 2017, 28: v50-v51. DOI: 10.1093/annonc/mdx362.020.Peer-Reviewed Original ResearchImplementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times.
Losk K, Freedman R, Lin N, Golshan M, Lester S, Pochebit S, Natsuhara K, Camuso K, King T, Bunnell C. Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times. Journal Of Clinical Oncology 2017, 35: 166-166. DOI: 10.1200/jco.2017.35.8_suppl.166.Peer-Reviewed Original ResearchOncotype DX testingChemotherapy initiationMedical oncologistsBreast cancerConsecutive breast cancer patientsAdjuvant chemotherapy initiationBreast cancer patientsOncotype DX resultsPathology reviewClinical outcomesTumor characteristicsMedical oncologyOncotype DXCancer patientsPatient satisfactionSurgery dateSurgical oncologyPatientsTurnaround timeSurgeryIntervention implementationMean timeOncologistsSignificant reductionOrder date
2016
Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?
Criscitiello C, Curigliano G, Burstein H, Wong S, Esposito A, Viale G, Giuliano M, Veronesi U, Santangelo M, Golshan M. Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity? European Journal Of Surgical Oncology 2016, 42: 1780-1786. PMID: 27825710, DOI: 10.1016/j.ejso.2016.10.011.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic Combined Chemotherapy ProtocolsAxillaBreast NeoplasmsClinical Decision-MakingFemaleGenes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseHereditary Breast and Ovarian Cancer SyndromeHumansLymph Node ExcisionMastectomyMastectomy, SegmentalMedical OveruseNeoadjuvant TherapyPatient PreferenceSurgical OncologyConceptsBreast conservationNeoadjuvant therapyBreast cancerSystemic therapyPathologic complete response rateComplete response rateBreast conservation ratesEffective systemic treatmentPatient-level variablesInvasive surgical approachNeoadjuvant trialsInoperable patientsSurgical overtreatmentSystemic treatmentSurgical approachSurgical benefitsOncology communityResponse ratePatientsTherapyCancerAggressive optionsMastectomySurgeonsConservation rate
2015
Tumor subtype and race in male breast cancer: A population-based cohort study.
Aydogan F, Sagara Y, Mallory M, Tukenmez M, Golshan M. Tumor subtype and race in male breast cancer: A population-based cohort study. Journal Of Clinical Oncology 2015, 33: 149-149. DOI: 10.1200/jco.2015.33.28_suppl.149.Peer-Reviewed Original ResearchMale breast cancerFemale breast cancerBreast cancerRace/ethnicityProgesterone receptorEstrogen receptorTumor subtypesAsian Pacific IslandersPopulation-based cohort studyEnd Results Program databaseBreast cancer subtypesDistribution of subtypesSEER databaseCohort studyFinal cohortHER2 statusProgram databaseNH blacksHispanic menCancer subtypesPatientsUnknown raceCancerSubtypesMolecular profiling
2014
Standardizing coordination between surgical oncology and reconstructive surgery for breast cancer patients undergoing mastectomy with immediate reconstruction.
Golshan M, Hergrueter C, Camuso K, Lin N, Cutone L, Hirshfield-Bartek J, Roberts P, Runkle W, Kadish S, Losk K, Bunnell C. Standardizing coordination between surgical oncology and reconstructive surgery for breast cancer patients undergoing mastectomy with immediate reconstruction. Journal Of Clinical Oncology 2014, 32: 110-110. DOI: 10.1200/jco.2014.32.30_suppl.110.Peer-Reviewed Original ResearchSurgery consultImmediate reconstructionInitial consultBreast cancer patientsPre-operative testingOptimal clinical outcomesOperating room availabilityDefinitive surgerySurgical consultClinical outcomesCancer CenterStandard referralCancer patientsPatient preferencesPatient referralPatient satisfactionCare coordinationReferral templatesSurgical oncologyBreast cancerReconstructive surgeryMastectomySurgical teamPatientsConsults
2010
Can axillary lymph node dissection be omitted in patients with breast cancer and positive sentinel nodes?
Dominici L, Golshan M. Can axillary lymph node dissection be omitted in patients with breast cancer and positive sentinel nodes? Minerva Surgery 2010, 65: 547-54. PMID: 21081866.Peer-Reviewed Original ResearchConceptsBreast cancerSentinel lymphAxillary lymph node dissectionPositive sentinel lymph nodesCompletion axillary dissectionLymph node dissectionPositive axillary nodesPositive sentinel nodesSentinel lymph nodesStandard of careInvasive surgical managementNegative axillaAxillary dissectionAxillary lymphNode dissectionAxillary nodesLymph nodesSentinel nodesSurgical managementSurgical proceduresPatientsLymphCancerDissectionTherapeutic purposes
2008
Young Breast Cancer Patients Undergoing Breast-Conserving Therapy: Role of BRCA1 and BRCA2
Bafford A, Garber J, Chittenden A, Golshan M. Young Breast Cancer Patients Undergoing Breast-Conserving Therapy: Role of BRCA1 and BRCA2. Methods Of Cancer Diagnosis, Therapy And Prognosis 2008, 1: 483-491. DOI: 10.1007/978-1-4020-8369-3_33.Peer-Reviewed Original ResearchBreast cancerYoung breast cancer patientsTumor suppressor geneBreast-Conserving TherapyInvasive breast cancerBreast cancer patientsCancer-related deathSporadic breast cancerSuppressor geneClassical tumor suppressor geneCancer patientsCommon cancerCancerRole of BRCA1WomenAmerican womenBRCA2BRCA1Cell cycle regulationDNA damageMultiple cellular processesPatientsTherapyDiseaseDiagnosisBreast Pain
Golshan M. Breast Pain. 2008, 345-346. DOI: 10.1007/978-0-387-75246-4_85.Peer-Reviewed Original ResearchBreast painFourth of womenOvarian estrogen productionBreast nodularityBreast symptomsHormonal milieuEstrogen productionCommon complaintPalpable abnormalityProgesterone secretionBreast cancerHormonal changesPainPatientsNodularityCommon typeMensesCancerBreastWomenHyperprolactinemiaCommon patternSymptomsMenstruationAbnormalitiesInvasive Breast Cancer
Golshan M. Invasive Breast Cancer. 2008, 337-339. DOI: 10.1007/978-0-387-75246-4_83.Peer-Reviewed Original Research
2006
11 Factors Associated With Involvement of Four or More Axillary Nodes for Sentinel Lymph Node Positive Patients
Katz A, Smith B, Golshan M, Niemierko A, Kobayashi W, Gadd M, Specht M, Rizk L, Kelada A, Taghian A. 11 Factors Associated With Involvement of Four or More Axillary Nodes for Sentinel Lymph Node Positive Patients. International Journal Of Radiation Oncology • Biology • Physics 2006, 66: s6-s7. DOI: 10.1016/j.ijrobp.2006.07.025.Peer-Reviewed Original Research
2004
Prediction of breast cancer size by ultrasound, mammography and core biopsy
Golshan M, Fung B, Wiley E, Wolfman J, Rademaker A, Morrow M. Prediction of breast cancer size by ultrasound, mammography and core biopsy. The Breast 2004, 13: 265-271. PMID: 15325659, DOI: 10.1016/j.breast.2004.05.005.Peer-Reviewed Original Research
2003
The effect of ipsilateral whole breast ultrasonography on the surgical management of breast carcinoma
Golshan M, Fung B, Wolfman J, Rademaker A, Morrow M. The effect of ipsilateral whole breast ultrasonography on the surgical management of breast carcinoma. The American Journal Of Surgery 2003, 186: 391-396. PMID: 14553857, DOI: 10.1016/s0002-9610(03)00280-0.Peer-Reviewed Original ResearchConceptsWhole-breast ultrasonographyBreast cancer patientsSurgical managementBreast ultrasonographyCancer patientsBreast cancerHistologic grade 2Percent of patientsBreast conservation therapyHigh-grade lesionsPrimary tumor siteFoci of carcinomaUltrasonography abnormalitiesYounger patientsConservation therapyWide resectionGrade lesionsPhysical examinationAdditional lesionsSignificant abnormalitiesBreast carcinomaPatientsGrade 2UltrasonographyTumor siteSentinel Lymph Node Biopsy Lowers the Rate of Lymphedema When Compared with Standard Axillary Lymph Node Dissection
Golshan M, Martin W, Dowlatshahi K. Sentinel Lymph Node Biopsy Lowers the Rate of Lymphedema When Compared with Standard Axillary Lymph Node Dissection. The American Surgeon 2003, 69: 209-212. PMID: 12678476, DOI: 10.1177/000313480306900306.Peer-Reviewed Original ResearchConceptsAxillary lymph node dissectionLymph node dissectionNode dissectionSentinel lymphArm circumferenceBreast cancerStandard axillary lymph node dissectionLong-term postoperative managementConventional axillary dissectionRate of lymphedemaAxillary node dissectionCent of patientsALND patientsArm edemaSLNB groupAxillary dissectionLymphedema ratePostoperative managementNonoperated sideLevel IPatientsData patientsSLNBLymphBiopsy